Drug Shortage Report for ORENCIA

Last updated on 2020-11-27 History
Report ID 128713
Drug Identification Number 02402475
Brand name ORENCIA
Common or Proper name Abatacept
Company Name BRISTOL-MYERS SQUIBB CANADA
Market Status MARKETED
Active Ingredient(s) ABATACEPT
Strength(s) 125MG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size 4 X 1ml
ATC code L04AA
ATC description IMMUNOSUPPRESSANTS
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2020-11-23
Actual start date
Estimated end date 2020-11-26
Actual end date 2020-11-26
Shortage status Resolved
Updated date 2020-11-27
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 2344 BOUL. ALFRED-NOBEL, SUITE 300
ST-LAURENT, QUEBEC
CANADA H4S 0A4
Company contact information For more information please contact the Customer Service Desk at 1-800-267-0005

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2020-11-27 English Compare
v5 2020-11-26 French Compare
v4 2020-11-26 English Compare
v3 2020-11-24 English Compare
v2 2020-11-23 French Compare
v1 2020-11-23 English Compare

Showing 1 to 6 of 6